Efficacy and Safety of HK-660S in the Treatment of Primary Sclerosing Cholangitis

Clinical trial NCT06975150 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06975150
Sponsor: CuromeBiosciences
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Sclerosing Cholangitis (PSC)

Start date: 2025-08-18
Primary completion: 2028-08-30
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.